| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |